Disease-modifying therapy for multiple sclerosis. / Behandling som begrenser multippel sklerose.
Tidsskr Nor Laegeforen
; 141(8)2021 05 25.
Article
en En, Nor
| MEDLINE
| ID: mdl-34047171
High-efficacy therapy from the time of diagnosis substantially improves the prognosis for multiple sclerosis. The national guidelines on MS nevertheless recommend less effective therapy for many patients, and must be updated in pace with medical advances. We consider in the following how multiple sclerosis should be treated.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Esclerosis Múltiple
Tipo de estudio:
Guideline
Límite:
Humans
Idioma:
En
/
Nor
Revista:
Tidsskr Nor Laegeforen
Año:
2021
Tipo del documento:
Article